Skip to main content

Advertisement

SpringerLink
Log in

Left main crossover stenting in a patient with severe thrombocytopenia due to aplastic anemia

  • Case Report
  • Published:
Cardiovascular Intervention and Therapeutics Aims and scope Submit manuscript

Abstract

A 76-year-old man with aplastic anemia presented with recurrent acute myocardial infarction (AMI) with heart failure. After the initial appearance of AMI approximately 2 months earlier, he had received conservative treatment/transfusion alone because of severe thrombocytopenia and anemia (platelet 11 × 103/μL, hemoglobin 6.4 g/dL). Refractory heart failure persisted despite repeated conservative treatment/transfusion for the second AMI, and therefore, we performed transradial coronary angiography and left main crossover stenting with a bare metal stent. His critical condition markedly improved; however, soon after discharge, he complicated with subdural hematoma. He has since been free of cardiovascular/hemorrhagic events for 7 months without antiplatelet/anticoagulant therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Toyama M, Watanabe S, Kobayashi T, Iida K, Koseki S, Yamaguchi I, et al. Two cases of acute myocardial infarction associated with aplastic anemia during treatment with anabolic steroids. Jpn Heart J. 1994;35:369–73.

    Article  CAS  PubMed  Google Scholar 

  2. Shin HS, Kang TS. A case of late stent thrombosis following platelet transfusion in a patient with aplastic anemia. Korean Circ J. 2012;42:54–7.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Overgaard CB, Ivanov J, Seidelin PH, Todorov M, Mackie K, Dzavík V. Thrombocytopenia at baseline is a predictor of inhospital mortality in patients undergoing percutaneous coronary intervention. Am Heart J. 2008;156:120–4.

    Article  PubMed  Google Scholar 

  4. Williamson DR, Albert M, Heels-Ansdell D, Arnold DM, Lauzier F, Zarychanski R, et al. PROTECT collaborators; Canadian Critical Care Trials Group; Australian and New Zealand Intensive Care Society Clinical Trials Group. Thrombocytopenia in critically ill patients receiving thromboprophylaxis: frequency, risk factors, and outcomes. Chest. 2013;144:1207–15.

    Article  PubMed  Google Scholar 

  5. Morici N, Cantoni S, Savonitto S. Antiplatelet therapy for patients with stable ischemic heart disease and baseline thrombocytopenia: ask the hematologist. Platelets. 2014;25:455–60.

    Article  CAS  PubMed  Google Scholar 

  6. Stouffer GA, Hirmerova J, Moll S, Rubery B, Napoli M, Ohman EM, et al. Percutaneous coronary intervention in a patient with immune thrombocytopenia purpura. Catheter Cardiovasc Interv. 2004;61:364–7.

    Article  PubMed  Google Scholar 

  7. Yusuf SW, Iliescu C, Bathina JD, Daher IN, Durand JB. Antiplatelet therapy and percutaneous coronary intervention in patients with acute coronary syndrome and thrombocytopenia. Tex Heart Inst J. 2010;37:336–40.

    PubMed  PubMed Central  Google Scholar 

  8. Sarkiss MG, Yusuf SW, Warneke CL, Botz G, Lakkis N, Hirch-Ginsburg C, Champion JC, Swafford J, Shaw AD, Lenihan DJ, Durand JB. Impact of aspirin therapy in cancer patients with thrombocytopenia and acute coronary syndromes. Cancer. 2007;109:621–7.

    Article  CAS  PubMed  Google Scholar 

  9. Hakim DA, Dangas GD, Caixeta A, Nikolsky E, Lansky AJ, Moses JW, et al. Impact of baseline thrombocytopenia on the early and late outcomes after ST-elevation myocardial infarction treated with primary angioplasty: analysis from the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) trial. Am Heart J. 2011;161:391–6.

    Article  PubMed  Google Scholar 

  10. Ali ZA, Qureshi YH, Karimi Galougahi K, Poludasu S, Roye S, et al. Effects of baseline and early acquired thrombocytopaenia on long-term mortality in patients undergoing percutaneous coronary intervention with bivalirudin. Eurointervention. 2016;11:e1627–38.

    Article  PubMed  Google Scholar 

  11. Cornet AD, Klein LJ, Groeneveld AB. Coronary stent occlusion after platelet transfusion: a case series. J Invasive Cardiol. 2007;19:E297–9.

    PubMed  Google Scholar 

  12. Steg PG, James SK, Atar D, Badano LP, Blömstrom-Lundqvist C, Borger MA, et al. Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC). ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J. 2012;33:2569–619.

    Article  CAS  PubMed  Google Scholar 

  13. O’Gara PT, Kushner FG, Ascheim DD, Casey DE Jr, Chung MK, de Lemos JA, American College of Cardiology Foundation, American Heart Association Task Force on Practice Guidelines, et al. ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2013;2013(127):e362–425.

    Google Scholar 

  14. Marsh JC, Ball SE, Cavenagh J, Darbyshire P, Dokal I, Gordon-Smith EC, et al. British Committee for Standards in Haematology. Guidelines for the diagnosis and management of aplastic anaemia. Br J Haematol. 2009;147:43–70.

    Article  CAS  PubMed  Google Scholar 

  15. Viollier R, Passweg J, Gregor M, Favre G, Kühne T, Nissen C, et al. Quality-adjusted survival analysis shows differences in outcome after immunosuppression or bone marrow transplantation in aplastic anemia. Ann Hematol. 2005;84:47–55.

    Article  PubMed  Google Scholar 

  16. Tantry US, Bonello L, Aradi D, Price MJ, Jeong YH, Angiolillo DJ, et al. Working Group on On-Treatment Platelet Reactivity. Consensus and update on the definition of on-treatment platelet reactivity to adenosine diphosphate associated with ischemia and bleeding. J Am Coll Cardiol. 2013;62:2261–73.

    Article  CAS  PubMed  Google Scholar 

  17. Sabate M, Cequier A, Iñiguez A, Serra A, Hernandez-Antolin R, Mainar V, et al. Everolimus-eluting stent versus bare-metal stent in ST-segment elevation myocardial infarction (EXAMINATION): 1 year results of a randomised controlled trial. Lancet. 2012;380:1482–90.

    Article  CAS  PubMed  Google Scholar 

  18. Palmerini T, Biondi-Zoccai G, Della Riva D, Mariani A, Sabaté M, Valgimigli M, et al. Clinical outcomes with drug-eluting and bare-metal stents in patients with ST-segment elevation myocardial infarction: evidence from a comprehensive network meta-analysis. J Am Coll Cardiol. 2013;62:496–504.

    Article  CAS  PubMed  Google Scholar 

  19. Sabaté M, Räber L, Heg D, Brugaletta S, Kelbaek H, Cequier A, et al. Comparison of newer-generation drug-eluting with bare-metal stents in patients with acute ST-segment elevation myocardial infarction: a pooled analysis of the EXAMINATION (clinical Evaluation of the Xience-V stent in Acute Myocardial INfArcTION) and COMFORTABLE-AMI (Comparison of Biolimus Eluted From an Erodible Stent Coating With Bare Metal Stents in Acute ST-Elevation Myocardial Infarction) trials. JACC Cardiovasc Inter. 2014;7:55–63.

    Article  Google Scholar 

  20. Palmerini T, Biondi-Zoccai G, Della Riva D, Stettler C, Sangiorgi D, D’Ascenzo F, et al. Stent thrombosis with drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis. Lancet. 2012;379:1393–402.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This article does not contain any studies with human participants or animals performed by any of the authors.

Author information

Authors and Affiliations

  1. Department of Cardiology, Kyoto First Red Cross Hospital, Honmachi, Higashiyama-ku, Kyoto, 605-0981, Japan

    Marie Nishikawa, Jun Shiraishi, Masaki Yashige, Masayuki Hyogo & Takahisa Sawada

  2. Department of Hematology, Kyoto First Red Cross Hospital, Honmachi, Higashiyama-ku, Kyoto, 605-0981, Japan

    Muneo Ohshiro

Authors
  1. Marie Nishikawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jun Shiraishi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Muneo Ohshiro
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Masaki Yashige
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Masayuki Hyogo
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Takahisa Sawada
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jun Shiraishi.

Ethics declarations

Conflict of interest

The authors have no conflicts of interest regarding the content of the manuscript.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Nishikawa, M., Shiraishi, J., Ohshiro, M. et al. Left main crossover stenting in a patient with severe thrombocytopenia due to aplastic anemia. Cardiovasc Interv and Ther 32, 409–415 (2017). https://doi.org/10.1007/s12928-016-0445-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12928-016-0445-6

Keywords

Search

Navigation